Colon adenocarcinoma (COAD) is one of the most common malignant tumors. Tumor mutation burden (TMB) has become an independent biomarker for predicting response to immune checkpoint inhibitors (ICIs). miRNAs play important role in cancer-related regulation. However, relationship between miRNA expression and TMB COAD remains unclear. Therefore, transcriptome profiling data, clinical annotation pr...